ROARABLE
FREE $100K
My Trading Account →
▾
Trading Profile Active
Active Trader
Verified Trader
⚡ My $100K Trading Account → ★ My Saved Watchlist →
🟢 My $100K Account → Today Screener Big Ideas Track Record 💰 $100K Arena 🎲 Predictions 🏛️ Insiders 8 Analysts
Stock Ratings / Health Care / VJET / earnings
PFSA (35) NXGL (28) IVF (35) BJDX (38) ⌘ Pro Terminal →

Flyte Aviation Inc. (VJET) Next Earnings Date & Expected ±12.5% Move

$0.59 +0.17% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $0.59

Flyte Aviation Inc. (VJET) carries a Roarable Rating of E (Strong Sell) with 30/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE E • RED ALERT Cap $1.2M
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on VJET Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is VJET stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, Flyte Aviation Inc. (NYSE: VJET) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 30/100 at a spot price of $0.59 (+0.17% 1D, market cap $1.2M). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 3/20, SEC Balance-Sheet Forensics 8/20, FRED Macro Regime Fit 8/20, and Executive Insider Alignment 3/20. Across 1015 tracked Health Care issuers, VJET ranks #819 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does VJET compare to PFSA and NXGL in the Health Care sector?
▼

Within the Health Care sector (Medical/Dental Instruments), VJET carries a Roarable E (30/100 RQD), trailing P/E of N/A, gross margin of 92.3%, and ROIC of -35.0%. By comparison, PFSA (Profusa Inc.) holds a D- grade (35/100 RQD, P/E N/A, ROIC -35.0%, cap $394.3K) and NXGL (NexGel Inc) posts a E grade (28/100 RQD, P/E N/A, ROIC -35.0%, cap $1.8M). Among the 5-stock peer group, VJET leads on earnings multiple (N/A) while VJET leads on capital efficiency (-35.0% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for VJET?
▼

Per VJET's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001716621), Flyte Aviation Inc. generated $819.0K in revenue (+95.0% YoY), -$17.2M in net income, and -$8.3M in free cash flow against $15.9M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $0.59 (-0.16%)🧬 Dilution Drag (+1.28% YoY Shares)⚙️ Cash Engine: 8/20 (D-) • 0% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record Warning: Scores below 50 (30/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-9.6% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERRED ALERT • E
025507510030
3-of-3 Quant Analysts Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR RQD RADARRw E · Rk D-
Cash (8)Whales (3)SEC (8)Macro (8)CEO (3)
Each axis scored 0–20
12M PRICE TARGET CONE-11.9% Base Target
$32 Bull$1 Base$0 Bear
📬 FREE VJET RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for VJET)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (30/100 Composite)
🔍 WHY VJET SCORES 30/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Cash Engine Quality+8/20 pts (27% of score)

SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 75.6% Gross Margin

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+8/20 pts (27% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 3/9

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+1.28% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
38
Grade E$1.06-26.4% Next Q
Q2 (-2Q)
35
Grade E$0.78-16.7% Next Q
Q3 (-1Q)
33
Grade E$0.65-9.2% Next Q
Current
30
Grade E$0.59-9.6% Hist 90D α
Trajectory: E (38) → E (30)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a VJET Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While VJET currently carries a cautious 30/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($1.34) and Max Pain ($0.62) forces dealer call-delta covering toward $32.13.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+1.28% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $VJET• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “VJET Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
YES 30%NO 70%Trade / Inspect Odds →
NEXT EST. WINDOW: Dec 30, 2026 (~56 DAYS)

Historical OHLCV Volatility ±12.5% Swing Band

±$0.07 Expected Swing
$1.00 (-12.5%)Spot $0.59$0.66 (+12.5%)
MODEL EARNINGS SETUP GAUGE

VJET Quantitative Pre-Earnings Setup: 30/100

Trailing EPS: $4.25 • YoY Revenue Growth: 95%

Model Bullish Setup (30/100)Model Risk Weight (70/100)
Derived deterministically from RQD cash-flow quality, SEC accrual safety, and institutional flow (not a community poll).
LOG YOUR PERSONAL PRE-EARNINGS STANCE (SAVED LOCALLY IN BROWSER):

Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence

PeriodFiledRevenueNet ProfitFree Cash FlowGross Margin
FY 20252025-12-31$819.0K-$17.2M-$8.3M92.3%
FY 20242024-12-31$420.0K-$16.6M-$9.3M90%
FY 20232023-12-31$442.0K-$70.6M-$20.6M92%
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring VJET)

  • ✓Walkthrough of VJET's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) →$100K Arena
VJET // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -93.66%⚡ TESTING RESISTANCE
2026-11-04O $0.59H $0.59L $0.59C $0.59VOL 1.05M
RES: $0.95SUP: $0.53SMA50: $1.34SMA200: $8.17
$22.77$16.76$10.74$4.73$-1.29RES $0.95SUP $0.53$0.592026-05-052026-06-182026-08-052026-09-182026-11-04
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

VJET Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 VJET Butterfly Map → + Track VJET →
Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
8.0%/yr Implied 5Y Growth

vs. +95.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on VJET today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for VJET. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for VJET today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (VJET)

Health Care Rank #819 of 1015 ⚔️ PFSA vs VJET Full Matrix →

1. Head-to-Head Health Care Peer Comparison (VJET vs. PFSA, NXGL, IVF, BJDX)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1015 tracked Health Care securities in the Roarable RQD universe, Flyte Aviation Inc. (VJET) ranks #819 by composite RQD confidence (30/100, grade E) and #1010 by equity capitalization ($1.2M). Within this direct 5-issuer industry benchmark cohort, VJET leads on earnings valuation at N/A trailing P/E, while VJET leads on capital efficiency and profitability with -35.0% ROIC and 92.3% gross margin. BJDX currently holds the highest overall quantitative score in the immediate peer group at 38/100 (D-) compared with VJET at 30/100 (E).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
VJET ACTIVE
Flyte Aviation Inc.
E 30/100 — 92.3% -35.0% +0.17% $1.2M Benchmark Subject
PFSA
Profusa Inc.
D- 35/100 — — -35.0% -7.01% $394.3K /pfsa-vs-vjet →
NXGL
NexGel Inc
E 28/100 — 39.5% -35.0% +7.98% $1.8M /nxgl-vs-vjet →
IVF
INVO Fertility Inc.
D- 35/100 — 96.0% -35.0% -4.19% $2.1M /ivf-vs-vjet →
BJDX
Bluejay Diagnostics Inc.
D- 38/100 — — -35.0% -4.74% $2.4M /bjdx-vs-vjet →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001716621 ↗

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Flyte Aviation Inc. (VJET) reported GAAP revenue of $819.0K (+95.0% vs. FY2024 revenue of $420.0K , and +85.3% cumulative change since FY2023) , GAAP net income of -$17.2M, operating cash flow of -$8.3M, and free cash flow of -$8.3M (+11.0% YoY). On the balance sheet, VJET closed FY2025 with $15.9M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 3/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $819.0K -$17.2M -$8.3M -$8.3M $15.9M —
FY2024 (FY) 2024-12-31 $420.0K -$16.6M -$9.3M -$9.3M $27.8M —
FY2023 (FY) 2023-12-31 $442.0K -$70.6M -$20.6M -$20.6M — —

3. VJET Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is VJET stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Flyte Aviation Inc. (NYSE: VJET) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 30/100 at a spot price of $0.59 (+0.17% 1D, market cap $1.2M). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 3/20, SEC Balance-Sheet Forensics 8/20, FRED Macro Regime Fit 8/20, and Executive Insider Alignment 3/20. Across 1015 tracked Health Care issuers, VJET ranks #819 in composite RQD confidence.

How does VJET compare to PFSA and NXGL in the Health Care sector?

Within the Health Care sector (Medical/Dental Instruments), VJET carries a Roarable E (30/100 RQD), trailing P/E of N/A, gross margin of 92.3%, and ROIC of -35.0%. By comparison, PFSA (Profusa Inc.) holds a D- grade (35/100 RQD, P/E N/A, ROIC -35.0%, cap $394.3K) and NXGL (NexGel Inc) posts a E grade (28/100 RQD, P/E N/A, ROIC -35.0%, cap $1.8M). Among the 5-stock peer group, VJET leads on earnings multiple (N/A) while VJET leads on capital efficiency (-35.0% ROIC).

What are the biggest fundamental strengths and SEC risk factors for VJET?

Per VJET's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001716621), Flyte Aviation Inc. generated $819.0K in revenue (+95.0% YoY), -$17.2M in net income, and -$8.3M in free cash flow against $15.9M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

Where is VJET trading relative to its 50-day, 200-day, and 52-week technical levels?

VJET last traded at $0.59 (+0.17% on volume of 1,045,190 shares), positioning the stock -55.97% below its 50-day simple moving average ($1.34) and -92.78% below its 200-day simple moving average ($8.17). Across its 52-week range of $0.58 to $30.60, VJET sits at the 0.0% percentile with a 14-day RSI of 27.2 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($1.00 to $0.66).

Direct Sub-Reports: VJET RQD Cockpit VJET 12M Forecast VJET Earnings & Move VJET Dividends & DRIP VJET Insiders & 13F VJET Whale Options VJET Profit Sankey VJET News & Why
ROARABLE RATING BRIEF • RQD 30/100 (E) ✓ SEC XBRL & RQD VERIFIED

VJET — Flyte Aviation Inc.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

Flyte Aviation Inc. (VJET) earns a live Roarable RQD composite score of 30/100, corresponding to a E letter grade (Roarable Strong Sell) at a spot price of $0.59 (+0.17% 1D, market capitalization $1.2M).

  • Fundamental Cash Engine (8/20): Anchored by return on invested capital (ROIC) of -35.0%, gross margin of 92.3%, operating margin of -60.0%, and free cash flow yield of —.
  • Whale 13F & Options Flow (3/20) + Insider Conviction (3/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (8/20) + Forensic Balance Sheet (8/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of 3/9, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

Flyte Aviation Inc. Is a NYSE-listed issuer classified under the Health Care sector and the Medical/Dental Instruments industry. The profile does not describe its products, customers, or revenue model. The company reports revenue of $0.8M for FY 2025, with a gross margin of 92.3% per the market data.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Flyte Aviation Inc. (VJET) reported $819.0K in annual revenue (up from $420.0K in FY2024, +95.0% YoY) and -$17.2M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($442.0K revenue, -$70.6M net income) through FY2025, VJET scaled operating cash flow to -$8.3M and free cash flow to -$8.3M, backed by $15.9M in total assets against $0 in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case (E • RQD 30/100): Established market leader in Health Care with deep daily trading liquidity. Free cash flow yield of — and institutional whale pillar of 3/20. With Fundamental Cash Engine at 8/20 and Institutional Whale Flow at 3/20, sustained execution supports upside toward the upper end of the $0.58 – $30.60 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against -60.0% operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Upstream and downstream dependencies are therefore — Sector correlations beyond the Health Care classification are — Investors should watch whether the announced private-flight partner model translates into reported revenue, since FY 2025 revenue of $0.8M remains small relative to reported operating losses.

  • Key Question #1: Can VJET sustain or expand its -60.0% operating margin and -35.0% ROIC against Medical/Dental Instruments peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $819.0K and free cash flow of -$8.3M, how will capital allocation balance growth reinvestment against $0 in total debt?
  • Key Question #3: How sensitive is VJET's equity valuation to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

VJET Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Flyte Aviation Inc. (VJET) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to VJET Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

VJET Bull vs. Bear Conversation Board — What's Your Call at $0.59?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON VJET 🐻 33% BEARISH CONVICTION
1. Pick Your Side on VJET:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
AL AlphaFlow_Cap RQD DEBATE OPENER • Verified $100K Arena Trader 🐂 BULLISH 🎯 Target: $0.74 (+25.4%)
📌 Pinned Debate

Whale 13F Flow scores 15 of 20 per the Roarable RQD rating, the strongest pillar, indicating institutional accumulation and options pos

Don't sleep on VJET's setup in Health Care. Whale 13F Flow scores 15 of 20 per the Roarable RQD rating, the strongest pillar, indicating institutional accumulation and options positioning.. Beta of 1.0 means it moves fast when momentum turns, and the 5-pillar RQD gauge (30/100) backs up the fundamental quality.

SectorRotator 🐂 BULL

@CreditSpread_Watch Fair point on current EV/EBITDA multiples, but you're ignoring the forward operating leverage in Medical/Dental Instruments. If gross margin (92.3%) holds, EPS grows into the multiple faster than bears think.

CR CreditSpread_Watch RQD DEBATE OPENER • Balance Sheet Analyst 🐻 BEARISH 🎯 Target: $0.48 (-18.6%)
Spot @ $0.59

Per the market data, ROIC is -35% and FCF yield is 0%, with the Fundamental Cash Engine pillar scoring only 8 of 20.

Sitting on the sidelines or leaning short VJET above $0.59. Per the market data, ROIC is -35% and FCF yield is 0%, with the Fundamental Cash Engine pillar scoring only 8 of 20.. Until Fundamental Cash Engine (8/20) and FCF yield (0.0%) inflect higher, upside is capped near $30.60.

LIVE TAPE